Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2020 | $494,275 | | grant/loan hybrid program |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2020 | $458,408 | | training reimbursement |
Intervet Inc. | Merck | Kansas | state | 2020 | undisclosed | | tax credit/rebate |
Novo Nordisk Research Center Seattle, Inc. | Novo Holdings A/S | Washington | state | 2020 | $4,725,452 | | tax credit/rebate |
Omeros Corporation | Omeros Corp. | Washington | state | 2020 | $2,125,967 | | tax credit/rebate |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2020 | $1,927,300 | | enterprise zone |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2020 | $1,038,094 | | tax credit/rebate |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2020 | $497,199 | | tax credit/rebate |
Idexx Distribution Inc | IDEXX Laboratories | Maine | state | 2020 | $209,498 | | tax credit/rebate |
Idexx Operations Inc | IDEXX Laboratories | Maine | state | 2020 | $114,127 | | tax credit/rebate |
Novavax, Inc. | Novavax Inc. | Maryland | local | 2020 | $1,000,000 | | grant/loan hybrid program |
EMD Holding Corporation | Merck KGaA (EMD) | Massachusetts | state | 2020 | $1,350,000 | | tax credit/rebate |
Blueprint Medicines Corporation | Blueprint Medicines | Massachusetts | state | 2020 | $1,065,000 | | tax credit/rebate |
Ultragenyx Pharmaceutical | Ultragenyx Pharmaceutical | Massachusetts | state | 2020 | $780,952 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2020 | $210,812 | | tax credit/rebate |
Bausch & Lomb Inc. | Bausch Health | New York | local | 2020 | $1,076,396 | | tax credit/rebate |
Regeneron 1 CSC Way Project | Regeneron Pharmaceuticals | New York | local | 2020 | $361,165 | | tax credit/rebate |
Regeneron 81 Columbia Project | Regeneron Pharmaceuticals | New York | local | 2020 | $192,947 | | tax credit/rebate |
RegeneronN | Regeneron Pharmaceuticals | New York | local | 2020 | $878,388 | | tax credit/rebate |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | local | 2020 | $3,137,267 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2020 | $168,371 | | tax credit/rebate |
BioCryst Pharmaceuticals, Inc. | Biocryst Pharmaceuticals | North Carolina | state | 2020 | $3,835 | | tax credit/rebate |
Chimerix, Inc. | Chimerix | North Carolina | state | 2020 | $56,926 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2020 | $17,084 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2020 | $9,685 | | tax credit/rebate |
Lundbeck NA, Ltd. | Lundbeck | North Carolina | state | 2020 | $36,097 | | tax credit/rebate |
Novartis Pharmaceuticals Corp. | Novartis | North Carolina | state | 2020 | $27,580 | | tax credit/rebate |
Novo Nordisk Pharmaceutical Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2020 | $168,537 | | tax credit/rebate |
Pfizer Research (NC), Inc. | Pfizer | North Carolina | state | 2020 | $20,518 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2020 | $236,439 | | tax credit/rebate |
UCB Biosciences, Inc. | UCB | North Carolina | state | 2020 | $216,022 | | tax credit/rebate |
UCB, Inc. | UCB | North Carolina | state | 2020 | $4,380 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2020 | $218,433 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2020 | $1,458,481 | | tax credit/rebate |
Exelixis, Inc. | Exelixis | California | state | 2020 | $7,000,000 | | tax credit/rebate |
Genentech USA, Inc | Roche | Oregon | state | 2020 | $1,573,000 | | grant |
Abbott Laboratories | Abbott Laboratories | Virginia | state | 2020 | $300,000 | | grant |
Bausch & Lomb | Bausch Health | Virginia | state | 2020 | $210,000 | | grant |
Pfizer, Inc. | Pfizer | Michigan | state | 2019 | $1,000,000 | | tax credit/rebate |
Abbott Laboratories | Abbott Laboratories | Ohio | local | 2019 | $2,530,230 | | tax credit/rebate |
SAFC Carlsbad, Inc. | Merck KGaA (EMD) | California | state | 2019 | $4,000,000 | | tax credit/rebate |
Exelixis, Inc. | Exelixis | California | state | 2019 | $3,000,000 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2019 | $180,014 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2019 | $39,219 | | tax credit/rebate |
IDEXX DIstribution, Inc. | IDEXX Laboratories | Kentucky | state | 2019 | $1,000,000 | | tax credit/rebate |
JANSSEN RESEARCH & DEVELOPMENT LLC | Johnson & Johnson | Pennsylvania | state | 2019 | $6,841 | | tax credit/rebate |
BOEHRINGER INGELHEIM FREMONT INC | Boehringer Ingelheim | California | state | 2019 | $343,449 | | training reimbursement |
VERTEX PHARMACEUTICALS (SAN DIEGO) LLC | Vertex Pharmaceuticals | California | state | 2019 | $16,570 | | training reimbursement |
Intervet Inc. | Merck | Kansas | state | 2019 | undisclosed | | grant |
IDEXX OPERATIONS INC | IDEXX Laboratories | Maine | state | 2019 | $26,789 | | property tax abatement |
IDEXX LABS, INC. | IDEXX Laboratories | Maine | state | 2019 | $17,942 | | property tax abatement |
ABBOTT DIAGNOSTICS SCARBOROUGH INC | Abbott Laboratories | Maine | state | 2019 | $7,368 | | property tax abatement |
IDEXX PHARMACEUTICALS INC | IDEXX Laboratories | Maine | state | 2019 | $2,511 | | property tax abatement |
MedImmune, LLC | AstraZeneca | Maryland | state | 2019 | $1,475,043 | | tax credit/rebate |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | Maryland | state | 2019 | $1,338,392 | | tax credit/rebate |
MacroGenics, Inc. | MacroGenics | Maryland | state | 2019 | $641,295 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2019 | $172,893 | | tax credit/rebate |
United Therapeutics Corporation & Subs | United Therapeutics | Maryland | state | 2019 | $129,675 | | tax credit/rebate |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2019 | $62,460 | | tax credit/rebate |
Pfizer Inc & Subsidiaries | Pfizer | Maryland | state | 2019 | $42,853 | | tax credit/rebate |
Emergent Biosolutions, Inc. and Subsidiaries | Emergent BioSolutions | Maryland | state | 2019 | $31,013 | | tax credit/rebate |
Otsuka America, Inc. & Subsidiaries | Otsuka Pharmaceutical | Maryland | state | 2019 | $26,526 | | tax credit/rebate |
Amgen, Inc. | Amgen | Maryland | state | 2019 | $26,263 | | tax credit/rebate |
Novo Nordisk Inc. | Novo Holdings A/S | Maryland | state | 2019 | $14,253 | | tax credit/rebate |
Incyte Corporation | Incyte Corp. | Maryland | state | 2019 | $5,472 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2019 | $280,119 | | tax credit/rebate |
Mallinckrodt Enterprises Holdings, Inc. | Mallinckrodt | North Carolina | state | 2019 | $6,922 | | tax credit/rebate |
Merck Sharp & Dohme Corp. II | Merck | North Carolina | state | 2019 | $4,974,750 | | grant |
PAREXEL International, LLC | Parexel International | North Carolina | state | 2019 | $4,194,000 | | grant |
Wyeth Holdings LLC | Pfizer | North Carolina | state | 2019 | $125,000 | | grant |
NOVO NORDISK RESEARCH CENTER SEATTLE, INC. | Novo Holdings A/S | Washington | state | 2019 | $7,847,528 | | tax credit/rebate |
OMEROS CORPORATION | Omeros Corp. | Washington | state | 2019 | $2,138,039 | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. (CD#3) | Regeneron Pharmaceuticals | New York | state | 2019 | $70,000,000 | | tax credit/rebate |
Bausch & Lomb Incorporated(2) | Bausch Health | New York | state | 2019 | $3,000,000 | | tax credit/rebate |
Abbott Laboratories | Abbott Laboratories | Ohio | state | 2019 | undisclosed | | enterprise zone |
Amneal Pharmaceuticals LLC 2019 Facility | Amneal Pharmaceuticals | New York | local | 2019 | $28,646 | | tax credit/rebate |
Bausch & Lomb Inc. | Bausch Health | New York | local | 2019 | $20,253 | | tax credit/rebate |
Regeneron 81 Columbia Project | Regeneron Pharmaceuticals | New York | local | 2019 | $197,545 | | tax credit/rebate |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2019 | $904,695 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2019 | $119,959 | | tax credit/rebate |
Regeneron Garage | Regeneron Pharmaceuticals | New York | local | 2019 | $104,551 | | tax credit/rebate |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2019 | $21,846 | | tax credit/rebate |
Regeneron Warehouse | Regeneron Pharmaceuticals | New York | local | 2019 | $189,845 | | tax credit/rebate |
Regeneron Garage Addition 25 Discovery Dr. | Regeneron Pharmaceuticals | New York | local | 2019 | $58,198 | | tax credit/rebate |
Regeneron 1CSC Office/Lab Extension | Regeneron Pharmaceuticals | New York | local | 2019 | $322,052 | | tax credit/rebate |
Regeneron Warehouse Expansion | Regeneron Pharmaceuticals | New York | local | 2019 | $1,026,828 | | tax credit/rebate |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2019 | $390,739 | | tax credit/rebate |
GLAXOSMITHKLINE & Stiefel Laboratories Inc. | GlaxoSmithKline | New York | local | 2019 | $556,419 | | tax credit/rebate |
LAX/Amneal Pharmaceuticals | Amneal Pharmaceuticals | New York | local | 2019 | $229,588 | | tax credit/rebate |
Regeneron 1 CSC Way Project | Regeneron Pharmaceuticals | New York | local | 2019 | $236,900 | | tax credit/rebate |
Regeneron at Global View | Regeneron Pharmaceuticals | New York | local | 2019 | $21,588 | | tax credit/rebate |
Regeneron Pharmaceuticals III | Regeneron Pharmaceuticals | New York | local | 2019 | $660,340 | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | local | 2019 | $723,229 | | tax credit/rebate |
Regeneron Pharmaceuticals II | Regeneron Pharmaceuticals | New York | local | 2019 | $283,003 | | tax credit/rebate |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | local | 2019 | $135,702 | | tax credit/rebate |
Valmed Pharmaceuticals, Inc. | AbbVie | New York | local | 2019 | $1,159 | | tax credit/rebate |
Abiomed, Inc | Johnson & Johnson | Massachusetts | state | 2019 | $459,125 | | tax credit/rebate |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | Massachusetts | state | 2019 | $2,250,000 | | tax credit/rebate |
EMD Holding Corporation | Merck KGaA (EMD) | Massachusetts | state | 2019 | $1,125,000 | | tax credit/rebate |
Ethicon, Inc. | Johnson & Johnson | Texas | state | 2019 | undisclosed | | enterprise zone |
Spark Therapeutics, Inc. | Roche | Pennsylvania | state | 2019 | $2,000,000 | | grant |